has role independent continuant benzamides pyridines antineoplastic agent aryl sulfide tyrosine kinase inhibitor indazoles vascular endothelial growth factor receptor antagonist axitinib An indazole substituted at position 3 by a 2-(pyridin-2-yl)vinyl group and at position 6 by a 2-(<em>N</em>-methylaminocarboxy)phenylsulfanyl group. Used for the treatment of advanced renal cell carcinoma after failure of a first line systemic treatment. CHEBI:66910